Canario, Norma T.

HRN: 06-06-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/11/2022
10/17/2022
IV
4.5gm Now Then 2.25
Q12
Infected Wound Right Foot
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: